OpGen Provides ATM Program Update
Dec 16, 2016 14:26 pm UTC| Business
GAITHERSBURG, Md., Dec. 16, 2016 -- OpGen, Inc. (NASDAQ:OPGN) announces that during the fourth quarter of 2016 it has issued approximately 3.6 million shares of its common stock under its previously announced “at the...
1ST Constitution Bancorp Declares Cash Dividend of $0.05 Per Common Share
Dec 16, 2016 14:15 pm UTC| Business
CRANBURY, N.J., Dec. 16, 2016 -- 1ST Constitution Bancorp (NASDAQ:FCCY), parent company of 1ST Constitution Bank, announced that its Board of Directors has declared a cash dividend of $0.05 per common share. The cash...
Vericel Corporation Prices $17 Million Public Offering of Common Stock
Dec 16, 2016 14:14 pm UTC| Business
CAMBRIDGE, Mass., Dec. 16, 2016 -- Vericel Corporation (NASDAQ:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today announced the...
Aptevo Therapeutics Announces Publication of Phase 2 Clinical Data for Otlertuzumab
Dec 16, 2016 14:05 pm UTC| Business
SEATTLE, Dec. 16, 2016 -- Aptevo Therapeutics Inc. (Nasdaq:APVO) a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced the publication of positive data from a Phase 2...
Unified Government Opens New Employee Health Center with Cerner
Dec 16, 2016 14:00 pm UTC| Business
KANSAS CITY, Mo. and KANSAS CITY, Kan., Dec. 16, 2016 -- The Unified Government of Wyandotte County and Kansas City, Kansas (UG), in collaboration with Cerner, a global leader in health care technology and The...
Avid Delivers Innovations for its State-of-the-art Graphics Authoring Software
Dec 16, 2016 14:00 pm UTC| Business
BURLINGTON, Mass., Dec. 16, 2016 -- Avid® (Nasdaq:AVID) today announced the availability of a new version of its state-of-the-art graphics authoring software, Avid 4Designer. As part of Avid’s commitment to offering the...
Dec 16, 2016 14:00 pm UTC| Business
SAN DIEGO, Dec. 16, 2016 -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) (“Company” or “Adamis”) today announced the resubmission of the Company’s New Drug Application (“NDA”) to the U.S. Food and Drug...
Markets Weekly outlook- Anticipating change: ECB Rate cut and bank earnings take center stage